<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract"><front><journal-meta><journal-id journal-id-type="nlm-ta">Open Forum Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">Open Forum Infect Dis</journal-id><journal-id journal-id-type="publisher-id">ofid</journal-id><journal-title-group><journal-title>Open Forum Infectious Diseases</journal-title></journal-title-group><issn pub-type="epub">2328-8957</issn><publisher><publisher-name>Oxford University Press</publisher-name><publisher-loc>US</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">5631442</article-id><article-id pub-id-type="doi">10.1093/ofid/ofx163.1297</article-id><article-id pub-id-type="publisher-id">ofx163.1297</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstracts</subject><subj-group subj-group-type="category-toc-heading"><subject>Poster Abstract</subject></subj-group></subj-group></article-categories><title-group><article-title>Impact of Personalized Audit and Feedback on Management of Pediatric Outpatient Community-Acquired Pneumonia</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Handy</surname><given-names>Lori</given-names></name><degrees>MD, MSCE</degrees><xref ref-type="aff" rid="AF0001">1</xref><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Cadilla</surname><given-names>Adriana</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="AF0003">3</xref></contrib><contrib contrib-type="author"><name><surname>Werk</surname><given-names>Lloyd</given-names></name><degrees>MD, MPH</degrees><xref ref-type="aff" rid="AF0004">4</xref></contrib><contrib contrib-type="author"><name><surname>Diaz</surname><given-names>Maria Carmen</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="AF0005">5</xref></contrib><contrib contrib-type="author"><name><surname>Franciosi</surname><given-names>James</given-names></name><degrees>MD, MSCE</degrees><xref ref-type="aff" rid="AF0006">6</xref></contrib><contrib contrib-type="author"><name><surname>Dent</surname><given-names>Joanne</given-names></name><degrees>RN, MS, PMP</degrees><xref ref-type="aff" rid="AF0007">7</xref></contrib><contrib contrib-type="author"><name><surname>Hossain</surname><given-names>Jobayer</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="AF0007">7</xref></contrib><contrib contrib-type="author"><name><surname>Crutchfield</surname><given-names>James</given-names><suffix>Jr.</suffix></name><degrees>PhD</degrees><xref ref-type="aff" rid="AF0008">8</xref></contrib><contrib contrib-type="author"><name><surname>Wysocki</surname><given-names>Timothy</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="AF0009">9</xref></contrib></contrib-group><aff id="AF0001">
<label>1</label>
<institution>Division of Infectious Diseases, Children’s Hospital of Philadelphia</institution>, <addr-line>Philadelphia, Pennsylvania</addr-line></aff><aff id="AF0002">
<label>2</label>
<institution>Division of Infectious Diseases, Nemours/A.I. duPont Hospital for Children</institution>, <addr-line>Wilmington, Delaware</addr-line></aff><aff id="AF0003">
<label>3</label>
<institution>Division of Infectious Diseases, Nemours Children’s Hospital</institution>, <addr-line>Orlando, Florida</addr-line></aff><aff id="AF0004">
<label>4</label>
<institution>Department of Pediatrics, Nemours Children’s Hospital</institution>, <addr-line>Orlando, Florida</addr-line></aff><aff id="AF0005">
<label>5</label>
<institution>Division of Emergency Medicine, Nemours/Alfred I. duPont Hospital for Children</institution>, <addr-line>Wilmington, Delaware</addr-line></aff><aff id="AF0006">
<label>6</label>
<institution>Division of Gastroenterology, Nemours Children’s Hospital</institution>, <addr-line>Orlando, Florida</addr-line></aff><aff id="AF0007">
<label>7</label>
<institution>Nemours/Alfred I. duPont Hospital for Children</institution>, <addr-line>Wilmington, Delaware</addr-line></aff><aff id="AF0008">
<label>8</label>
<institution>Lockheed Martin Rotary and Mission Systems</institution>, <addr-line>Orlando, Florida</addr-line></aff><aff id="AF0009">
<label>9</label>
<institution>Nemours Children’s Health System</institution>, <addr-line>Jacksonville, Florida</addr-line></aff><author-notes><fn id="fn-0001"><p>
<bold>Session:</bold> 169. Stewardship: Pediatric Antimicrobial Stewardship</p><p>
<italic>Friday, October 6, 2017: 12:30 PM</italic>
</p></fn></author-notes><pub-date pub-type="collection"><season>Fall</season><year>2017</year></pub-date><pub-date pub-type="epub" iso-8601-date="2017-10-04"><day>04</day><month>10</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>04</day><month>10</month><year>2017</year></pub-date><volume>4</volume><issue>Suppl 1</issue><issue-title>ID Week 2017 Abstracts</issue-title><fpage>S501</fpage><lpage>S501</lpage><permissions><copyright-statement>© The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America.</copyright-statement><copyright-year>2017</copyright-year><license license-type="cc-by-nc-nd" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p></license></permissions><self-uri xlink:href="ofx163.1297.pdf"></self-uri><abstract><title><offsets xml_i="5978" xml_f="5986" txt_i="11" txt_f="19">Abstract</offsets></title><sec id="s1"><title><offsets xml_i="6014" xml_f="6024" txt_i="20" txt_f="30">Background</offsets></title><p><offsets xml_i="6035" xml_f="6458" txt_i="31" txt_f="454">Community-acquired pneumonia (CAP) is a common infection in children. Guidelines recommend amoxicillin as first line therapy for CAP, while macrolides are recommended for school-aged children with atypical pneumonia. Despite guidelines, antibiotic choice for CAP varies widely among providers. We aimed to determine the impact of outpatient audit and feedback to individual providers on adherence with published guidelines.</offsets></p></sec><sec id="s2"><title><offsets xml_i="6488" xml_f="6495" txt_i="456" txt_f="463">Methods</offsets></title><p><offsets xml_i="6506" xml_f="7231" txt_i="464" txt_f="1189">We conducted a randomized controlled trial of primary care clinicians in a multi-state primary care network from 8/2016–2/2017. Providers received baseline education. The intervention included personalized feedback from investigators at 1-month intervals on the provider’s management of a case of CAP identified by ICD-10-CM codes. Prescription counts of guideline-recommended antibiotic therapy were compared between groups by Pearson’s chi-squared. Performance scores incorporating diagnostic and treatment decisions such as physical examination elements, antibiotics and medication dosing appropriate for a CAP encounter as defined by clinical practice guidelines were calculated for each encounter during study intervals.</offsets></p></sec><sec id="s3"><title><offsets xml_i="7261" xml_f="7268" txt_i="1191" txt_f="1198">Results</offsets></title><p><offsets xml_i="7279" xml_f="7713" txt_i="1199" txt_f="1630">Among the 43 providers, the majority were physicians (76% control, 86% intervention). There were no significant differences in work hours, years since board certification, sex or race between groups. 316 distinct cases of CAP were diagnosed (214 control; 102 intervention). In patients &lt;5 years, there was no significant difference in prescription of amoxicillin between groups (61/103 (59.2%) control; 23/48 (47.9%) intervention, </offsets><italic><offsets xml_i="7721" xml_f="7724" txt_i="1630" txt_f="1633">P =</offsets></italic><offsets xml_i="7733" xml_f="7935" txt_i="1633" txt_f="1835"> 0.19). In patients ≥5 years, there was a significant difference in prescription of guideline recommended antibiotics of amoxicillin or azithromycin (81/103 (78.6%) control; 48/51 (94.1%) intervention, </offsets><italic><offsets xml_i="7943" xml_f="7949" txt_i="1835" txt_f="1838">P &lt;</offsets></italic><offsets xml_i="7958" xml_f="8075" txt_i="1838" txt_f="1955"> 0.05). There was a small, but apparent upward trend in mean performance scores in the intervention group (Figure 1).</offsets></p></sec><sec id="s4"><title><offsets xml_i="8105" xml_f="8115" txt_i="1957" txt_f="1967">Conclusion</offsets></title><p><offsets xml_i="8126" xml_f="8464" txt_i="1968" txt_f="2306">Personalized, scheduled audit and feedback in the outpatient setting had a small but measurable impact on improving physician adherence with guidelines. Audit and feedback alone is insufficient to substantially improve guideline adherence in the management of CAP and should be combined with other antimicrobial stewardship interventions.</offsets></p></sec><sec id="s5"><title><offsets xml_i="8494" xml_f="8505" txt_i="2308" txt_f="2319">Disclosures</offsets></title><p><offsets xml_i="8516" xml_f="8517" txt_i="2320" txt_f="2321">
</offsets><bold><offsets xml_i="8523" xml_f="8535" txt_i="2321" txt_f="2333">All authors:</offsets></bold><offsets xml_i="8542" xml_f="8567" txt_i="2333" txt_f="2358"> No reported disclosures.</offsets></p><fig fig-type="figure" id="F1" orientation="portrait" position="float"><graphic xlink:href="OFIDIS_ofx163_IF0557"></graphic></fig></sec></abstract><counts><page-count count="1"></page-count></counts></article-meta></front></article>